德科维里马特抗病毒活性和毒素病毒抗性的机制
Riccardo Vernuccio1, Alejandro Martínez León2, Chetan S Poojari2
1G5 Structural Biology of Infectious Diseases, Institut Pasteur, Université Paris Cité, Paris, France.
Research square
|October 14, 2024
概括
一种mopox病毒药物Tecovirimat通过迫使病毒脂酶F13进行二元化而起作用. 导致药物耐药性的突变发生在这个二元化部位,影响治疗的有效性.
科学领域:
- 病毒学 病毒学
- 结构生物学 结构生物学
- 药物发现 药物发现 药物发现
背景情况:
- 马普克斯病毒 (MPXV) 爆发是一个日益严重的全球健康问题,需要有效的抗病毒治疗.
- 德科维里马特是mopox的主要治疗剂,但其精确的作用机制和抗药性途径仍然不完全理解.
- 由于病毒脂酶F13突变的特征,出现了抗tecovirimat的MPXV菌株,这对公共卫生构成了重大挑战.
研究的目的:
- 阐明tecovirimat对mopox病毒施加抗病毒作用的分子机制.
- 确定tecovirimat与病毒脂酶F13.1的相互作用的结构基础.
- 调查F13突变对特科维里马特疗效和耐药性的影响.
主要方法:
- 采用X射线晶体学来确定F13同极体的结构,无论是在它的apo形式还是与tecovirimat.complex中.
- 生物化学试验被用来评估药物诱导的溶液中F13的二元化.
- 进行了基于细胞的测试,以评估tecovirimat和F13突变对病毒退出和复制的影响.
主要成果:
- 德科维里马特作为分子剂起作用,诱导mopox病毒脂酶F13.的二分化.
- 晶体结构显示了tecovirimat结合在F13同极体接口.
- 临床F13脱离突变位于二聚体接口,破坏tecovirimat介导的二聚化,并赋予耐药性.
- 在溶液和细胞环境中,Tecovirimat诱导的F13二元化得到证实.
结论:
- 德科维里马特的作用方式涉及促进F13二分化,这对于阻止病毒输出至关重要.
- 赋予耐药性的F13突变直接干扰这种药物诱导的二分化过程.
- 了解这种机制为改善对MPOX疫情的监测和开发下一代抗病毒药物提供了基础.
- 这项研究提供了对设计更强效和更有弹性的治疗方法的见解.
更多相关视频
相关概念视频
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cytotoxic T Cells-mediated Immune Response
857
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
857


